Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Onconova Therapeutics (ONTX)
NASDAQ:ONTX
RESEARCH TOOLSreports
Onconova Therapeutics (ONTX) Stock Price & Analysis
1,793 Followers
ONTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.55 - $1.45
Previous Close$1.01
Volume217.09K
Average Volume (3M)76.91K
Market Cap
$21.21M
Enterprise Value$21.21M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-1.0
Beta1.45
Next Earnings
May 14, 2024EPS Estimate
-$0.23Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.96
Shares Outstanding21,003,409
10 Day Avg. Volume94,489
30 Day Avg. Volume76,912
Standard Deviation0.37
R-Squared0.04
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)1.46
Price to Sales (P/S)93.86
Price to Cash Flow (P/CF)-1.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue93.86
Enterprise Value/Gross Profit93.86
Enterprise Value/Ebitda-1.02
Forecast
1Y Price Target
$7.00Price Target Upside593.07% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Onconova Therapeutics News
PremiumCompany Announcements
Onconova Therapeutics’ Strategic Acquisition and Corporate Transformation
Ownership Overview
51.20% Insiders
4.22% Mutual Funds
3.61% Other Institutional Investors
40.97% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ONTX FAQ
What was Onconova Therapeutics’s price range in the past 12 months?
Onconova Therapeutics lowest stock price was $0.55 and its highest was $1.45 in the past 12 months.
What is Onconova Therapeutics’s market cap?
Currently, no data Available
When is Onconova Therapeutics’s upcoming earnings report date?
Onconova Therapeutics’s upcoming earnings report date is May 14, 2024 which is in 30 days.
How were Onconova Therapeutics’s earnings last quarter?
Onconova Therapeutics released its earnings results on Mar 07, 2024. The company reported -$0.28 earnings per share for the quarter, missing the consensus estimate of -$0.253 by -$0.027.
Is Onconova Therapeutics overvalued?
According to Wall Street analysts Onconova Therapeutics’s price is currently Undervalued.
Does Onconova Therapeutics pay dividends?
Onconova Therapeutics does not currently pay dividends.
What is Onconova Therapeutics’s EPS estimate?
Onconova Therapeutics’s EPS estimate is -$0.23.
How many shares outstanding does Onconova Therapeutics have?
Onconova Therapeutics has 21,003,408 shares outstanding.
What happened to Onconova Therapeutics’s price movement after its last earnings report?
Onconova Therapeutics reported an EPS of -$0.28 in its last earnings report, missing expectations of -$0.253. Following the earnings report the stock price went up 2.222%.
Which hedge fund is a major shareholder of Onconova Therapeutics?
Among the largest hedge funds holding Onconova Therapeutics’s share is Caxton Associates LP. It holds Onconova Therapeutics’s shares valued at N/A.
---
Onconova Therapeutics Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$7.00 (593.07% Upside)
$7.00 (593.07% Upside)
Crowd Wisdom
Very Positive
Last 7 Days ▼ 2.4%
Last 30 Days ▲ 9.3%
Last 30 Days ▲ 9.3%
Technicals
SMA
Positive
20 days / 200 days
Momentum
42.65%
12-Months-Change
Fundamentals
Return on Equity
-84.30%
Trailing 12-Months
Asset Growth
-38.24%
Trailing 12-Months
Company Description
Onconova Therapeutics
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA.
---
ONTX Stock 12 Months Forecast
Average Price Target
$7.00
▲(593.07% Upside)
Technical Analysis
Best Analysts Covering ONTX
1 Year
1 Year Success Rate
5/16 ratings generated profit
1 Year Average Return
-28.48%
reiterated a buy rating last month
Copying Robert LeBoyer's trades and holding each position for 1 Year would result in 31.25% of your transactions generating a profit, with an average return of -28.48% per trade.
---